Nifty 50 Tests 23,077 Support, Banking and Pharma Stocks May Rise

The Nifty 50 is testing a key support level at 23,077. This is a critical point after a period of market drops.
By Newsroom | Finance, India |

As of April 6, 2026, the Nifty 50 is testing a technical floor near the 23,077 level. Market strategist Rohit Srivastava of Indiacharts posits that the current corrective phase is reaching exhaustion. Data indicates a specific divergence where the Bank Nifty exhibits higher resilience compared to the broader index, leading to expectations of a reversal or, at minimum, a stabilization phase.

Core Signal: Market proximity to the 23,077 support zone suggests the end of the current correction cycle, with banking and pharmaceutical stocks identified as primary rotation targets.

Market correction nearing its end; bet on banking, pharma: Rohit Srivastava - 1

Sectoral Dynamics and Divergence

While the broader indices face downward pressure, the Nifty Pharma index has demonstrated distinct technical strength, breaking a two-year consolidation pattern above 23,500. Investors are navigating a fragmented landscape:

  • Banking: Favored for relative stability against broader market volatility.

  • Pharma: Seen as a breakout candidate following prolonged consolidation.

  • IT/Infrastructure: Analysts such as Aditya Shah and Gurmeet Chadha suggest a move toward stock-specific selectivity rather than sector-wide acquisition, favoring EPC firms and mid-cap IT for AI-driven potential.

Comparative Sentiment

IndicatorStatusOutlook
Nifty 50Approaching 23,077Support Testing
Pharma IndexBreakout confirmedPositive
Geopolitical/OilRising tensionVolatility Risk

Background and Context

The market has endured a period of significant price adjustment. Throughout mid-2025 and into early 2026, participants dealt with the convergence of geopolitical instability and elevated crude prices. The absence of fresh domestic catalysts has left the market reliant on technical support levels to define the floor of this Correction.

Read More: Lawrence Dallaglio accused of spending £200,000 during bankruptcy

Reflective analysis shows that current investor sentiment—measured as cautiously neutral—remains vulnerable to external Volatility spikes, particularly as global equity markets, including the US, face their own records and potential risks. The current shift from a broader decline to a more selective, sector-led focus reflects a market attempting to identify new growth vectors in a high-cost environment.

Frequently Asked Questions

Q: What is the Nifty 50 doing on April 6, 2026?
The Nifty 50 is close to the 23,077 support level. This suggests the current market drop might be ending soon.
Q: Which stocks might do better now?
Banking and pharmaceutical stocks are expected to do better. The Pharma index has already shown strength by going above 23,500.
Q: What about IT and Infrastructure stocks?
Analysts suggest picking specific IT and infrastructure companies, especially those in EPC or mid-cap IT, for potential growth.
Q: Why has the market been falling?
The market has seen price drops due to global issues like geopolitical problems and high oil prices since mid-2025.
Q: What is the market sentiment now?
Investors are cautiously neutral and sensitive to sudden global market changes, especially from the US.